Researchers at Yale Cancer Center have made a breakthrough finding that could lead to a therapies for glioblastoma and other ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related ...

Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe active lupus, a retrospective study shows.

The FDA has agreed to review an application from Roche that seeks approval in the U.S. of obinutuzumab as a treatment for lupus nephritis.

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into "cold" tumors and flip on an immune ...

Lupus Alert Day serves a vital purpose. It encourages others to learn more about lupus, share information on social media, ...

Even with significant expansion in the global market for antibodies used in clinical care and research, scientists recognize that there is still untapped potential for finding new antibodies. Many ...

it has several limitations that may be overcome instead through bispecific T-cell-engaging antibodies, according to a speaker. Chimeric antigen receptor T-cell therapy improves not only lupus ...

32,404 people played the daily Crossword recently. Can you solve it faster than others?32,404 people played the daily Crossword recently. Can you solve it faster than others?

Lupus-related antibody shows promise in enhancing cancer treatment efficacy. ScienceDaily . Retrieved April 2, 2025 from www.sciencedaily.com / releases / 2025 / 03 / 250325141527.htm ...